Risk factors for QTc interval prolongation
- 459 Downloads
Prolongation of the QTc interval may result in Torsade de Pointes, a ventricular arrhythmia. Numerous risk factors for QTc interval prolongation have been described, including the use of certain drugs. In clinical practice, there is much debate about the management of the risks involved. In this study, we quantified the effect of these risk factors on the length of the QTc interval.
We analyzed all ECGs that were taken during routine practice between January 2013 and October 2016 in the Spaarne Gasthuis, a general teaching hospital in the Netherlands. We collected laboratory values in the week before the ECG recording and the drugs prescribed. For the identification of risk factors, we used multilevel linear regression analysis to correct for multiple ECG recordings per patient.
We included 133,359 ECGs in our study, taken in 40,037 patients. Patients using one QT-prolonging drug had a 11.08 ms (95% CI 10.63–11.52; p < 0.001) longer QTc interval. Patients using two QT-prolonging drugs had a 3.04 ms (95% CI 2.06–4.02; p < 0.001) increase in the QTc interval compared to patients using one QT-prolonging drug. Women had a longer QTc interval compared to men (16.30 ms 95% CI 14.59–18.01; p < 0.001). The QTc interval increased with increasing age, but the difference between men and women diminished. Other independent risk factors that significantly prolonged the QTc interval with at least 10 ms were hypokalemia, hypocalcemia, and the use of loop diuretics.
We identified and quantified various risk factors for QTc interval prolongation.
KeywordsLong QT syndrome/chemically induced Electrocardiography Risk assessment Drug-related side effects and adverse reactions Hospital information systems
We would like to thank Pieter G. Postema for his useful comments in preparing this paper.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
For this type of study, formal consent is not required.
- 1.Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC (2006) Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47(2):362–367. https://doi.org/10.1016/j.jacc.2005.08.067 CrossRefPubMedGoogle Scholar
- 2.Tisdale J, Jaynes H, Kingery J, Mourad N, Trujillo T, Overholser B, Kovacs RJ (2013) Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 6(4):479–487. https://doi.org/10.1161/CIRCOUTCOMES.113.000152 CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Benoit S, Mendelsohn A, Nourjah P, Staffa J, Graham D (2005) Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 12(4):363–368. https://doi.org/10.1097/01.hjr.0000173110.21851.a9 CrossRefPubMedGoogle Scholar
- 5.Sohaib SMA, Papacosta O, Morris R, Macfarlane P, Whincup P (2008) Length of the QT interval: determinants and prognostic implications in a population-based prospective study of older men. J Electrocardiol 41(6):704–710. https://doi.org/10.1016/j.jelectrocard.2008.01.010 CrossRefPubMedGoogle Scholar
- 13.Woosley, RL and Romero, KA (2015) QT drug list. http://wwwCrediblemedsorg Accessed Oct 2015
- 14.Bazett HC (1920) An analysis of the time-relations of the electrocardiograms. Heart 7:353–370Google Scholar
- 15.EMEA (1997) The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. http://www.fda.gov/ohrms/dockets/ac/03/briefing/pubs/cpmp.pdf, http://www.fda.gov/ohrms/dockets/ac/03/briefing/pubs/cpmp.pdf
- 17.Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, Ector J, Willems R (2016) Which QT correction formulae to use for QT monitoring? J Am Heart Assoc 5. https://doi.org/10.1161/JAHA.116.003264
- 22.Kurokawa J, Kodama M, Clancy CE, Furukawa T (2016) Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes. Pharmacol Ther . https://doi.org/10.1016/j.pharmthera.2016.09.004
- 27.Poon K, Okin PM, Kligfield P (2005) Diagnostic performance of a computer-based ECG rhythm algorithm. J Electrocardiol 38(3):235–238. https://doi.org/10.1016/j.jelectrocard.2005.01.008 CrossRefPubMedGoogle Scholar